Medifast (MED) Other financing activities (2010 - 2021)

Medifast has reported Other financing activities for 12 years, with the latest figure at $34000.0 in Q3 2021.

• For the quarter ending Q3 2021, Other financing activities fell 5.56% year-over-year to $34000.0; the trailing twelve-month figure through Sep 2021 stood at $1.9 million (up 233.81% YoY), and the FY2020 full-year result was $551000.0, down 96.09% from the prior year.
• Other financing activities for Q3 2021 stood at $34000.0, up from $26000.0 in the prior quarter.
• The five-year high for Other financing activities was $2.2 million in Q4 2017, with the low at $9000.0 in Q2 2020.
• Historically, Other financing activities has averaged $372937.5 across 5 years, with a median of $35000.0 in 2018.
• Annual changes were most pronounced in 2018 — Other financing activities sank 78.46% — and 2021, when it jumped 271.05%.
• Medifast's Other financing activities stood at $2.2 million in 2017, then slumped by 78.46% to $471000.0 in 2018, then slumped by 92.99% to $33000.0 in 2019, then tumbled by 42.42% to $19000.0 in 2020, then surged by 78.95% to $34000.0 in 2021.
• The last three Other financing activities figures came in at $34000.0 (Q3 2021), $26000.0 (Q2 2021), and $1.8 million (Q1 2021), per Business Quant data.